Company intelligence / Profile preview

PKA

Lakefield, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

PKA SoftTouch has developed a patented, single-use, retractable microneedle injection device designed to deliver liquid drugs and vaccines into the skin (interstitial layer) in a pain‑free, safe, and cost‑effective manner; proof‑of‑concept trials have been completed and veterinary and first‑in‑human clinical trials are planned to support licensing with pharmaceutical partners.[1][2][6][7]

Modalities: DeviceDrug delivery device
Industry: Consumable Medical Devices

Partnerships

Planned technology licensing partnerships with pharmaceutical companies to fill and commercialize the Micro-Needle device with their drugs and vaccines[1][2][4]

Beyond the preview

Go deeper on PKA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PKA.

Explore the full profile